Takhzyro Found More Effective Than Cinryze at Preventing HAE Attacks

Takhzyro Found More Effective Than Cinryze at Preventing HAE Attacks

291424

Takhzyro Found More Effective Than Cinryze at Preventing HAE Attacks

Takhzyro (lanadelumab) is more effective than Cinryze at preventing swelling attacks in people with hereditary angioedema (HAE), a new study indicates. Analyses suggested that treatment with Takhzyro reduced the rates of HAE attack by 46–73% as compared with Cinryze in an indirect comparison of previous studies. Titled “Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses,” the new study was published in the journal Drugs…

You must be logged in to read/download the full post.